Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia

Menarini Receives Fda Orphan Drug Designation For Sel24/men1703, A First In Class, Dual Pim/flt3 Inhibitor For The Treatment Of Acute Myeloid Leukemia

Facebook Comments

Leave a Reply

CommentLuv badge